ATE444737T1 - Pharmakologisch aktive ionisierbare substanzen enthaltende neue pharmazeutische formulierungen sowie verfahren zu deren herstellung - Google Patents
Pharmakologisch aktive ionisierbare substanzen enthaltende neue pharmazeutische formulierungen sowie verfahren zu deren herstellungInfo
- Publication number
- ATE444737T1 ATE444737T1 AT91920634T AT91920634T ATE444737T1 AT E444737 T1 ATE444737 T1 AT E444737T1 AT 91920634 T AT91920634 T AT 91920634T AT 91920634 T AT91920634 T AT 91920634T AT E444737 T1 ATE444737 T1 AT E444737T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmacologically active
- production
- pharmaceutical formulations
- substances containing
- new pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9003903A SE9003903D0 (sv) | 1990-12-07 | 1990-12-07 | New pharmaceutical formulations |
PCT/SE1991/000814 WO1992010171A1 (en) | 1990-12-07 | 1991-12-03 | New pharmaceutical formulations containing a pharmacologically active ionizable substance as well as process for the preparation thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE444737T1 true ATE444737T1 (de) | 2009-10-15 |
Family
ID=20381122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT91920634T ATE444737T1 (de) | 1990-12-07 | 1991-12-03 | Pharmakologisch aktive ionisierbare substanzen enthaltende neue pharmazeutische formulierungen sowie verfahren zu deren herstellung |
Country Status (17)
Country | Link |
---|---|
US (2) | US5707656A (de) |
EP (1) | EP0560816B1 (de) |
JP (1) | JP3276956B2 (de) |
AT (1) | ATE444737T1 (de) |
AU (1) | AU656346B2 (de) |
CA (1) | CA2097176C (de) |
DE (1) | DE69133623D1 (de) |
EE (1) | EE03105B1 (de) |
FI (1) | FI932553A (de) |
HU (1) | HU218661B (de) |
IE (1) | IE914136A1 (de) |
IS (1) | IS1749B (de) |
NO (1) | NO305536B1 (de) |
PT (1) | PT99720B (de) |
SE (1) | SE9003903D0 (de) |
WO (1) | WO1992010171A1 (de) |
YU (1) | YU186791A (de) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69738966D1 (de) * | 1996-12-20 | 2008-10-16 | Mcneil Ppc Inc | Durch ionenaustauscherharze verabreichte hustenmittel |
EP1204406A2 (de) * | 1999-07-29 | 2002-05-15 | Roxane Laboratories, Inc. | Opioidhaltige formulierung mit verzögerter freisetzung |
US20030118641A1 (en) * | 2000-07-27 | 2003-06-26 | Roxane Laboratories, Inc. | Abuse-resistant sustained-release opioid formulation |
CN1610551A (zh) * | 2001-07-06 | 2005-04-27 | 恩德制药公司 | 用作止痛剂的6-羟基羟吗啡酮的肠胃外给药 |
WO2003020242A1 (en) * | 2001-08-29 | 2003-03-13 | Srl Technologies, Inc. | Sustained release preparations |
AU2003230805A1 (en) * | 2002-04-05 | 2003-10-27 | Penwest Pharmaceuticals Co. | Sustained release metoprolol formulations |
US7314640B2 (en) * | 2003-07-11 | 2008-01-01 | Mongkol Sriwongjanya | Formulation and process for drug loaded cores |
US20050265955A1 (en) * | 2004-05-28 | 2005-12-01 | Mallinckrodt Inc. | Sustained release preparations |
JP2006296511A (ja) * | 2005-04-15 | 2006-11-02 | Transcutaneous Technologies Inc | 外用剤、外用剤の塗布方法、イオントフォレーシス装置及び経皮パッチ |
JP2006346368A (ja) * | 2005-06-20 | 2006-12-28 | Transcutaneous Technologies Inc | イオントフォレーシス装置及びその製造方法 |
JPWO2007010900A1 (ja) * | 2005-07-15 | 2009-01-29 | Tti・エルビュー株式会社 | 貼付位置表示機能付き経皮吸収用パッチ及びイオントフォレーシス装置 |
JP2007037868A (ja) * | 2005-08-05 | 2007-02-15 | Transcutaneous Technologies Inc | 経皮投与装置及びその制御方法 |
US8386030B2 (en) * | 2005-08-08 | 2013-02-26 | Tti Ellebeau, Inc. | Iontophoresis device |
US20070060860A1 (en) * | 2005-08-18 | 2007-03-15 | Transcutaneous Technologies Inc. | Iontophoresis device |
WO2007026671A1 (ja) * | 2005-08-29 | 2007-03-08 | Transcu Ltd. | センサからの情報により投与すべき薬剤の選定を行うイオントフォレーシス装置 |
CA2619661A1 (en) * | 2005-09-16 | 2007-03-22 | Tti Ellebeau, Inc. | Catheter-type iontophoresis device |
US20070071807A1 (en) * | 2005-09-28 | 2007-03-29 | Hidero Akiyama | Capsule-type drug-releasing device and capsule-type drug-releasing device system |
WO2007038028A1 (en) * | 2005-09-28 | 2007-04-05 | Tti Ellebeau, Inc. | Iontophoresis apparatus and method to deliver active agents to biological interfaces |
US20090299265A1 (en) * | 2005-09-30 | 2009-12-03 | Tti Ellebeau, Inc. | Electrode Assembly for Iontophoresis Having Shape-Memory Separator and Iontophoresis Device Using the Same |
BRPI0616771A2 (pt) * | 2005-09-30 | 2011-06-28 | Tti Ellebeau Inc | dispositivo de iontoforese para liberar múltiplos agentes ativos para interfaces biológicas |
US20090187134A1 (en) * | 2005-09-30 | 2009-07-23 | Hidero Akiyama | Iontophoresis Device Controlling Amounts of a Sleep-Inducing Agent and a Stimulant to be Administered and Time at Which the Drugs are Administered |
US20070197955A1 (en) * | 2005-10-12 | 2007-08-23 | Transcutaneous Technologies Inc. | Mucous membrane adhesion-type iontophoresis device |
US20080193514A1 (en) * | 2006-11-02 | 2008-08-14 | Transcu Ltd. | Compostions and methods for iontophoresis delivery of active ingredients through hair follicles |
JPWO2008087803A1 (ja) * | 2007-01-16 | 2010-05-06 | 国立大学法人北海道大学 | 抗酸化成分を封入したイオントフォレーシス用リポソーム製剤 |
JP2010187707A (ja) * | 2007-06-12 | 2010-09-02 | Hokkaido Univ | インスリンを封入したイオントフォレーシス用リポソーム製剤 |
TW201026347A (en) * | 2008-09-10 | 2010-07-16 | Transcu Ltd | Apparatus and method to dispense HPC-based viscous liquids into porous substrates, e. g., continuous web-based process |
US9238078B2 (en) | 2009-04-03 | 2016-01-19 | Coating Place, Inc. | Modified-release pharmaceutical drug composition |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4983392A (en) * | 1983-11-14 | 1991-01-08 | Bio-Mimetics, Inc. | Bioadhesive compositions and methods of treatment therewith |
US4692462A (en) * | 1985-03-18 | 1987-09-08 | Menley & James Laboratories, Ltd. | Compositions and method of controlling transdermal penetration of topical and systemic agents |
EP0199855A1 (de) * | 1985-05-02 | 1986-11-05 | Gist-Brocades N.V. | Trimethoprim und ein Sulfonamid enthaltende Tabletten |
JPS62223112A (ja) * | 1986-03-25 | 1987-10-01 | Rooto Seiyaku Kk | 歯周病治療剤 |
IE62100B1 (en) * | 1986-07-30 | 1994-12-14 | Fisons Corp | Coated ion exchange resins |
DE3740684A1 (de) * | 1987-12-01 | 1989-06-15 | Woehr Otto Gmbh | Parksystem |
MC2025A1 (fr) * | 1988-04-20 | 1990-04-25 | Asta Pharma Ag | Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controlee |
IL90245A (en) * | 1988-05-11 | 1994-04-12 | Glaxo Group Ltd | Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it |
CA2002492A1 (en) * | 1988-11-11 | 1990-05-11 | Sandra T. A. Malkowska | Pharmaceutical ion exchange resin composition |
US5149523A (en) * | 1989-06-20 | 1992-09-22 | Aktiebolaget Hassle | Polystyrenesulfonate-drug complex and solid dosage forms thereof |
-
1990
- 1990-12-07 SE SE9003903A patent/SE9003903D0/xx unknown
-
1991
- 1991-11-27 YU YU186791A patent/YU186791A/sh unknown
- 1991-11-28 IE IE413691A patent/IE914136A1/en not_active Application Discontinuation
- 1991-12-03 WO PCT/SE1991/000814 patent/WO1992010171A1/en active Application Filing
- 1991-12-03 AU AU89305/91A patent/AU656346B2/en not_active Ceased
- 1991-12-03 CA CA002097176A patent/CA2097176C/en not_active Expired - Fee Related
- 1991-12-03 AT AT91920634T patent/ATE444737T1/de not_active IP Right Cessation
- 1991-12-03 EP EP91920634A patent/EP0560816B1/de not_active Expired - Lifetime
- 1991-12-03 HU HU9301671A patent/HU218661B/hu not_active IP Right Cessation
- 1991-12-03 JP JP50011692A patent/JP3276956B2/ja not_active Expired - Fee Related
- 1991-12-03 DE DE69133623T patent/DE69133623D1/de not_active Expired - Fee Related
- 1991-12-04 US US07/802,325 patent/US5707656A/en not_active Expired - Lifetime
- 1991-12-06 IS IS3787A patent/IS1749B/is unknown
- 1991-12-06 PT PT99720A patent/PT99720B/pt active IP Right Grant
-
1993
- 1993-06-04 FI FI932553A patent/FI932553A/fi unknown
- 1993-06-04 NO NO932053A patent/NO305536B1/no not_active IP Right Cessation
-
1994
- 1994-03-22 US US08/216,028 patent/US5709882A/en not_active Expired - Lifetime
- 1994-11-17 EE EE9400416A patent/EE03105B1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0560816B1 (de) | 2009-10-07 |
JP3276956B2 (ja) | 2002-04-22 |
FI932553A0 (fi) | 1993-06-04 |
JPH06503311A (ja) | 1994-04-14 |
NO305536B1 (no) | 1999-06-21 |
IS3787A7 (is) | 1992-06-08 |
FI932553A (fi) | 1993-06-04 |
HUT64213A (en) | 1993-12-28 |
SE9003903D0 (sv) | 1990-12-07 |
CA2097176A1 (en) | 1992-06-08 |
EE03105B1 (et) | 1998-08-17 |
IE914136A1 (en) | 1992-06-17 |
AU656346B2 (en) | 1995-02-02 |
IS1749B (is) | 2000-07-11 |
US5707656A (en) | 1998-01-13 |
PT99720A (pt) | 1992-10-30 |
US5709882A (en) | 1998-01-20 |
WO1992010171A1 (en) | 1992-06-25 |
DE69133623D1 (de) | 2009-11-19 |
CA2097176C (en) | 2002-03-26 |
PT99720B (pt) | 2002-04-29 |
HU218661B (hu) | 2000-10-28 |
EP0560816A1 (de) | 1993-09-22 |
AU8930591A (en) | 1992-07-08 |
YU186791A (sh) | 1994-04-05 |
NO932053D0 (no) | 1993-06-04 |
NO932053L (no) | 1993-07-20 |
HU9301671D0 (en) | 1993-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE444737T1 (de) | Pharmakologisch aktive ionisierbare substanzen enthaltende neue pharmazeutische formulierungen sowie verfahren zu deren herstellung | |
DE3481612D1 (de) | Gewisse 3-amino-1-benzazepin-2-on-1-alkansaeuren, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung. | |
DE68904326D1 (de) | Physiologisch aktive substanzen enthaltende mikrosphaeren des polymilchsaeuretyps sowie verfahren zu deren herstellung. | |
ATE18397T1 (de) | Benzazepin-2-one, verfahren zu ihrer herstellung, pharmazeutische praeparate die diese verbindungen enthalten, sowie die verbindungen zur therapeutischen verwendung. | |
DK0436370T3 (da) | Farmaceutisk præparat til kontrolleret afgivelse og fremgangsmåde til fremstilling deraf | |
DE3481170D1 (de) | Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung. | |
ATE160725T1 (de) | Verfahren zur herstellung von arzneiformulierungen | |
ATA293589A (de) | Neue chinolinsulfonaminoderivate und verfahren zu deren herstellung sowie pharmazeutische zusammensetzung | |
ATA86885A (de) | Verfahren zur herstellung lagerstabiler, schnellzerfallender pharmazeutischer wirkstoff-presslinge | |
DE68901771T2 (de) | Phospholipid enthaltende zusammensetzung, verfahren zu deren herstellung und verwendung als hilfsstoff fuer pharmazeutische substanzen. | |
PT78710B (de) | Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung | |
ATE243193T1 (de) | Benzocycloheptene, verfahren zu ihrer herstellung,pharmazeutische präparate die diese enthalten sowie deren verwendung zur herstellung von arzneimitteln | |
ATE23266T1 (de) | Pharmazeutische produkte in formen mit verzoegerter abgabe und verfahren an deren herstellung. | |
ATE15196T1 (de) | N-substituierte 2-pyridylindole, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung. | |
AT399504B (de) | Neue aminopropoxyimino-cycloalkanderivate, deren herstellung, arzneimittel, die diese verbindungen als wirkstoff enthalten sowie verfahren zur herstellung derselben | |
DE68906461D1 (de) | Feste arzneidosis in form eines tablettentriturats sowie verfahren zu deren herstellung. | |
AT375940B (de) | Verfahren zur herstellung neuer 10-halogen-14-oxo-15-hydroxy-e-homoeburnane (3 alpha,17 alpha) sowie deren epimeren, optisch aktiven antipoden und physiologisch vertraeglichen saeureadditionssalze | |
LU84492A1 (de) | Cumarin-derivate,verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische praeparate | |
PT69963A (de) | Alpha-alkylaminoalkyl-hydroxy-benzylalkohole verfahren zu ihrer herstellung pharmazeutische praparate enthaltend diese verbindungen sowie ihre therapeutische verwendung | |
ATE81586T1 (de) | Arzneiformulierung zur transdermalen absorption des wirkstoffs sowie verfahren zu deren herstellung. | |
DE3875460T2 (de) | Arzneiformulierung zur transdermalen absorption des wirkstoffs sowie verfahren zu deren herstellung. | |
ATA52288A (de) | Malonsaeurederivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzung, enthaltend diese verbindungen | |
ATE36320T1 (de) | Beta-oxo-alpha-carbamoyl-pyrrolpropionitrile, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |